Trial Profile
Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Linagliptin/metformin (Primary) ; Metformin (Primary)
- Indications Diabetic complications; Hyperglycaemia
- Focus Therapeutic Use
- Acronyms e-PREDICE
- 31 Oct 2020 This trial has been completed in Poland, according to European Clinical trials database record.
- 08 Aug 2016 This trial was prematurely ended on Lithuania, according to European Clinical Trials Database record.
- 24 Dec 2014 New trial record